An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.

Rainone, Michael; Singh, Isha; Salo-Mullen, Erin E; Stadler, Zsofia K; O'Reilly, Eileen M

Rainone, Michael; Singh, Isha; Salo-Mullen, Erin E; Stadler, Zsofia K; O'Reilly, Eileen M.

Afiliación

Rainone M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Singh I; Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York.
Salo-Mullen EE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Stadler ZK; Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York.
O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

JAMA Oncol ; 6(5): 764-771, 2020 05 01.

Article en En | MEDLINE | ID: mdl-32053139

Asunto(s)

Adenocarcinoma/genética; Carcinoma Ductal Pancreático/genética; Predisposición Genética a la Enfermedad/genética; Mutación de Línea Germinal/genética; Células Germinativas; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Mutación de Línea Germinal / Predisposición Genética a la Enfermedad / Carcinoma Ductal Pancreático Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Oncol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google